Bombay experience in intensive respiratory care over 6 years.
The experience of the intensive respiratory care in 930 cases treated from 1983 for 4 years and in 404 cases over the next 2 years is reported. The background operational problems are stressed. Those between age 10 and 50 years did significantly better (p less than 0.05). The survival over the first 4 years in IPPR cases was 16.3% and in non IPPR group 71.8%; over the next 2 years, the former group, survival was 32.4 and 36.3%. The survival in asthmatic patients was high (76%). In cases with organophosphorus poisoning (without IPPR), survival was 81% while in IPPR group it was 29%. In 1988, the results in this group were better due to more aggressive management. In autopsy data on 85 cases, infection was not a major feature in those dying within 24 hours. The survival in COPD cases showed significant relation to age (p less than 0.05), initial arterial pO2 below 60 mm (p less than 0.01) and arterial pH below 7.3 (p less than 0.01). In cases with pneumonia (also asthma) younger cases did better (p less than 0.05) as also those with pneumonia and initial pO2 above 60 mm (p less than 0.01) and pH above 7.3 (p less than 0.001). When pneumonia was community acquired, survival (64.8%) was better than when it was hospital acquired (24%; p less than 0.01). Only the need for IPPR affected survival in trauma group. The major cause of death was infection with Klebsiella, Pseudomonas, Staphylococci and other gram--ve organisms. It is concluded that with proper planning and training, the IRCU does provide a useful mode of treatment in selected patients with respiratory problems.
Kamat
S R
SR
Heera
S
S
Potdar
P V
PV
Shah
S V
SV
Bhambure
N M
NM
Mahashur
A A
AA
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007710:Klebsiella Infections / Q000453:epidemiology*; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D008171:Lung Diseases / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000453:epidemiology*; D012124:Respiratory Care Units; D012131:Respiratory Insufficiency / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000453:epidemiology*